# BioCryst Pharmaceuticals Inc. (BCRX) — Shareholder Equity

## Annual Shareholder Equity (USD)

| Year | Shareholder Equity |
| --- | --- |
| 2025 | -$119M |
| 2024 | -$476M |
| 2023 | -$456M |
| 2022 | -$295M |
| 2021 | -$107M |
| 2020 | -$19M |
| 2019 | $38M |
| 2018 | $49M |
| 2017 | $84M |
| 2016 | $2M |
| 2015 | $48M |
| 2014 | $76M |
| 2013 | -$1M |
| 2012 | -$454,000 |
| 2011 | $15M |
| 2010 | $66M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/BCRX/shareholders-equity)
